FDA

叫停“枪魁”，在为“xx的希望”鸣锣开道

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-warns-newly-discovered-potential-drug-interaction-may-reduce

Based on a recently completed non-clinical laboratory study, the FDA is revising the fact sheet for health care providers that accompanies the drug to state that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended as it may result in reduced antiviral activity of remdesivir. The agency is not aware of instances of this reduced activity occurring in the clinical setting but is continuing to evaluate all data related to remdesivir.

 

那么，“希望”在哪里

https://www.washingtonpost.com/business/2020/06/29/gilead-sciences-remdesivir-cost-coronavirus/

Gilead sets price of coronavirus drug remdesivir at $3,120 as Trump administration secures supply for 500,000 patients

Gilead Sciences, the maker of the first covid-19 treatment found to have worked in clinical trials, remdesivir, said Monday it will charge U.S. hospitals $3,120 for the typical patient with private insurance.

Soon after the announcement, the Trump administration said it had secured nearly all of the company’s supply of the drug for use in U.S. hospitals through September, with a contract for 500,000 treatment courses, which it will make available to hospitals at Gilead’s price.

更TM缺德的是：卖给其它国家会便宜1/4。发展中国家更低。

Other developed countries will pay 25 percent less than the United States, a discount Gilead said reflects a need to make the drug as widely available as possible throughout the world.

The company has licensed generic manufacturers to produce the drug for developing countries, which will receive the treatment “at a substantially lower cost,” the company said.

 

所有跟帖： 

• 够黑的。。。 -樱紫- ♀ (0 bytes) () 06/30/2020 postreply 18:49:02